Medy-Tox Inc. (086900.KQ)
KRW 124900.0
(-2.42%)
KRW 124900.0
(-2.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1456.65 KRW | -76.13% |
| 2022 | 5491.68 KRW | -62.35% |
| 2021 | 14.58 Thousand KRW | 416.43% |
| 2020 | -4609.84 KRW | -213.8% |
| 2019 | 4050.83 KRW | -63.55% |
| 2018 | 11.11 Thousand KRW | 2.96% |
| 2017 | 10.79 Thousand KRW | 19.07% |
| 2016 | 9064.60 KRW | 40.45% |
| 2015 | 6453.81 KRW | -2.24% |
| 2014 | 6601.94 KRW | 207.94% |
| 2013 | 2143.92 KRW | -7.35% |
| 2012 | 2314.10 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -218.32 KRW | 28.26% |
| 2024 Q2 | 1695.08 KRW | 876.38% |
| 2023 Q2 | 1273.00 KRW | 50.06% |
| 2023 FY | - KRW | -76.13% |
| 2023 Q4 | -304.34 KRW | 11.81% |
| 2023 Q1 | 848.32 KRW | 1162.79% |
| 2023 Q3 | -345.11 KRW | -127.11% |
| 2022 Q3 | 2118.94 KRW | -30.85% |
| 2022 FY | - KRW | -62.35% |
| 2022 Q4 | -79.82 KRW | -103.77% |
| 2022 Q2 | 3064.30 KRW | 282.63% |
| 2022 Q1 | 800.85 KRW | 138.28% |
| 2021 FY | - KRW | 416.43% |
| 2021 Q1 | 8629.91 KRW | 412.03% |
| 2021 Q2 | 4951.07 KRW | -42.63% |
| 2021 Q3 | 3225.94 KRW | -34.84% |
| 2021 Q4 | -2092.02 KRW | -164.85% |
| 2020 Q3 | -9.07 KRW | 98.82% |
| 2020 Q4 | -2765.72 KRW | -30393.05% |
| 2020 FY | - KRW | -213.8% |
| 2020 Q2 | -765.62 KRW | 12.89% |
| 2020 Q1 | -878.91 KRW | -451.84% |
| 2019 FY | - KRW | -63.55% |
| 2019 Q1 | 2042.03 KRW | -21.3% |
| 2019 Q2 | 1622.54 KRW | -20.54% |
| 2019 Q4 | -159.27 KRW | -133.26% |
| 2019 Q3 | 478.88 KRW | -70.49% |
| 2018 Q4 | 2594.56 KRW | 13.36% |
| 2018 FY | - KRW | 2.96% |
| 2018 Q3 | 2288.75 KRW | -24.59% |
| 2018 Q2 | 3035.27 KRW | -4.69% |
| 2018 Q1 | 3184.75 KRW | -5.68% |
| 2017 Q3 | 2046.21 KRW | -35.21% |
| 2017 Q1 | 2606.30 KRW | 12.74% |
| 2017 Q2 | 3158.26 KRW | 21.18% |
| 2017 Q4 | 3376.60 KRW | 65.02% |
| 2017 FY | - KRW | 19.07% |
| 2016 Q4 | 2311.81 KRW | 3.47% |
| 2016 Q3 | 2234.30 KRW | -8.35% |
| 2016 Q2 | 2437.83 KRW | 17.18% |
| 2016 Q1 | 2080.49 KRW | 18.62% |
| 2016 FY | - KRW | 40.45% |
| 2015 Q2 | 1797.17 KRW | 37.94% |
| 2015 Q1 | 1302.91 KRW | 29.86% |
| 2015 Q4 | 1753.89 KRW | 9.62% |
| 2015 Q3 | 1600.00 KRW | -10.97% |
| 2015 FY | - KRW | -2.24% |
| 2014 Q1 | 988.05 KRW | 58.2% |
| 2014 Q4 | 1003.29 KRW | -69.75% |
| 2014 Q2 | 1303.22 KRW | 31.9% |
| 2014 Q3 | 3316.44 KRW | 154.48% |
| 2014 FY | - KRW | 207.94% |
| 2013 Q2 | 618.02 KRW | 68.29% |
| 2013 Q4 | 624.55 KRW | 16.92% |
| 2013 FY | - KRW | -7.35% |
| 2013 Q1 | 367.24 KRW | -32.38% |
| 2013 Q3 | 534.15 KRW | -13.57% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | 543.12 KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 193.398% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | 598.665% |
| BINEX Co., Ltd. | 151.04 KRW | -864.413% |
| Bioneer Corporation | -410.19 KRW | 455.116% |
| Anterogen.Co.,Ltd. | -291.93 KRW | 598.972% |
| MEDIPOST Co., Ltd. | 287.00 KRW | -407.544% |
| CrystalGenomics, Inc. | -661.00 KRW | 320.371% |
| Helixmith Co., Ltd | -1543.76 KRW | 194.357% |
| Chabiotech Co.,Ltd. | -149.80 KRW | 1072.397% |
| Peptron, Inc. | -773.61 KRW | 288.293% |
| Amicogen, Inc. | -583.58 KRW | 349.606% |
| Genexine, Inc. | -1652.14 KRW | 188.167% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | 4635.025% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 156.133% |
| ALTEOGEN Inc. | -65.27 KRW | 2331.73% |
| PharmaResearch Co., Ltd. | 7502.00 KRW | 80.583% |
| SillaJen, Inc. | -179.98 KRW | 909.34% |
| JETEMA, Co., Ltd. | 783.21 KRW | -85.985% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | 210.035% |
| Genomictree Inc. | -391.00 KRW | 472.545% |
| MedPacto, Inc. | -1664.87 KRW | 187.493% |
| D&D Pharmatech | 409.19 KRW | -255.984% |
| EASY BIO,Inc. | 455.00 KRW | -220.143% |
| GI Innovation, Inc. | -1285.69 KRW | 213.297% |